Colloidal Silver and Ebola: What We Know So Far
Which, finally, brings us to the topic of colloidal silver and Ebola. Here’s the good news:
Back in 2008, the U.S. Department of Defense (DOD) in conjunction with several other federal agencies quietly conducted clinical research into the use of silver nanoparticles against Ebola and other hemorrhagic fever viruses.
And what they found was astonishing. They discovered that silver nanoparticles were highly effective against these deadly viruses, including the Ebola virus.
They later presented their findings to federal health regulators and other national health authorities. But it was all kept top secret. The presentation was called “Silver Nanoparticles Neutralize Hemorrhagic Fever Viruses.”
And the gist of the presentation was that silver nanoparticles displayed “powerful neutralizing effects against hemorrhagic fever viruses,” including Arenavirus and Filovirus (i.e., Ebola).
This clinical presentation was conducted under the auspices of the DOD’s Defense Threat Reduction Agency (DTRA) and the U.S. Strategic Command (USSTRATCOM) Center for Combating Weapons of Mass Destruction.
And the presentation was given by researchers from the Applied Biotechnology Branch, 711th Human Performance Wing of the Air Force Research Laboratory.
In other words, those are the big guns, folks! Which is to say, those are the very people responsible for keeping this nation safe from outside threats like bioterrorism.
That clinical presentation, made to federal regulators and national health authorities, was later summarized in a printed document, de-classified, and cleared for public release.
But there was no news media hoopla surrounding the release of this information. Not a peep.
And to this very day, to my knowledge, there still hasn’t been a single report in the mainstream news media on the release of this important information, in spite of the fact that Department of Defense researchers found antimicrobial silver to be profoundly effective against Ebola and other hemorrhagic fever viruses, under certain circumstances which we’ll discuss below.
Before we get into the results of this research, as documented in the published version of the DOD presentation, it’s important to note that one of the main tasks of the DOD’s Defense Threat Reduction Agency is to “anticipate and mitigate future threats long before they have a chance to harm the United States and our allies.”
In other words, the researchers were specifically looking for ways to stop Ebola or other hemorrhagic fever viruses from damaging our national security.
And the results they found when using silver nanoparticles for that precise purpose were strikingly positive -- enough so to warrant not just the presentation to health and regulatory authorities, but its later publication and public release.
What Researchers Discovered
The researchers tested silver nanoparticles of several different sizes and concentrations on infected cells in vitro (meaning, in the test tube).
And they concluded that silver nanoparticles were able to neutralize hemorrhagic fever viruses inside the cells by “decreasing S segment gene expression and concomitantly decreasing progeny virus production.”
Translation: Silver stops the Ebola virus and related hemorrhagic fever viruses from replicating inside the cells. And when there’s no viral replication inside the cells, there’s no spread of infection!
The researchers had discovered the holy grail Ebola treatments. But they also discovered that neutralization of the virus by silver occurs during the early phases of viral replication.
Therefore, they pointed out that for antimicrobial silver to be effective against Ebola and other hemorrhagic fever viruses, the treatment would have to be administered PRIOR to viral infection or at least within the first few hours after initial exposure to the virus.
In other words, for antimicrobial silver to be effective, an exposed person would need to have already been taking it, or at the very least would have to start taking it within a few short hours of exposure to an infected individual.
Another interesting thing the researchers discovered is that while an enzymatic protein called Cathepsin B has been shown to play an essential role in Ebola virus replication, silver nanoparticles work to decrease cathepsin activity, thus further limiting viral replication in the cell and subsequent spread of the virus to other cells.
And by far the most interesting thing the researchers discovered (at least, to me) is that only very low concentrations of silver nanoparticles were necessary to prevent replication of the virus.
Indeed, low concentrations of 10 ppm nanosilver appears to have worked better than higher concentrations of 25 ppm or 50 ppm nanosilver. This means there’s no need for overly high silver concentrations.
What’s more, the smallest silver particles tested by the researchers worked far better than the larger silver particles tested.
This demonstrates once more that the use of very small silver particles is far more important than the “ppm” or concentration of the colloidal silver solution one is using.
Simply put, smaller silver particles penetrate cells and tissues easier, and are therefore better able to get to the point of infection before the virus spreads.
Here's a link to the printed version of the DOD clinical presentation (_http://thesilveredge.com/study-defense-threat-reduction-agency-silver-nanoparticles-neutralize-hemorrhagic-fever-viruses.shtml), so you can scroll through it and read it for yourself. It’s technical. But if you take your time it’s relatively understandable.
The one thing they can't sell you, is your own immune system, so they will never promote things like cold adaptation, keto, orthomolecular nutrition, Golden Seal, colloidal silver etc}